Popular Research Topics by Year

• cisplatin
• everolimus
• gemcitabine
• mtor inhibitor
• urothelial carcinoma

• abdominal pain
• adult
• aged
• article
• bcg vaccine
• bladder cancer
• bladder carcinoma
• cancer combination chemotherapy
• carcinoma in situ
• clinical article
• continuous infusion
• diarrhea
• disease free interval
• drug efficacy
• drug response
• drug safety
• drug tolerability
• drug treatment failure
• drug withdrawal
• endocrine disease
• everolimus
• female
• gastrointestinal disease
• gemcitabine
• hematologic disease

• No data

• No data

• buparlisib
• phosphatidyl 3-inositol kinase (pi3k)/akt/mechanistic target of rapamycin (mtor) pathway
• targeted therapy
• urothelial carcinoma

• adenocarcinoma
• immunotherapy
• small cell carcinoma
• squamous cell carcinoma
• urothelial carcinoma
• variant histology

• adverse event
• antibodies, monoclonal, humanized
• antineoplastic agent
• antineoplastic combined chemotherapy protocols
• atezolizumab
• b7-h1 antigen
• bladder tumor
• cisplatin
• clinical trial
• cystectomy
• deoxycytidine
• doxecitine
• female
• gemcitabine
• human
• humans
• male
• monoclonal antibody
• multicenter study
• muscle
• muscles
• neoadjuvant therapy
• neoplasm invasiveness
• neoplasm recurrence, local
• pathology

• advanced cancer
• adverse events
• alopecia
• anticancer therapy
• body weight loss
• bronchoscopy
• cancer chemotherapy
• cancer grading
• constipation
• corticosteroid
• decreased appetite
• diarrhea
• disease exacerbation
• drug safety
• dry eye
• duloxetine
• dysgeusia
• enfortumab vedotin
• eye disease
• eye drops
• fatigue
• gabapentin
• health care personnel
• human
• hyperglycemia

• No data